A meta-analysis of blood fatty acids in people with learning disorders with particular interest in arachidonic acid

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 81, Issue 5-6, 2009, Pages 373-389

  Morse, N L ^a,b  

^a Clinical Research Coordinator of Efamol Ltd   (United Kingdom)

^b NONE   (Canada)

Author keywords

Arachidonic acid; Attention deficit hyperactivity disorder; Docosahexaenoic acid; Dyslexia; Dyspraxia; Learning disorders; Omega 3 fatty acids

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; PLACEBO; PRIMROSE OIL;

ARTICLE; ASPERGER SYNDROME; ATTENTION DEFICIT DISORDER; AUTISM; BRAIN FUNCTION; CLINICAL TRIAL; DEVELOPMENTAL COORDINATION DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIETARY INTAKE; DNA POLYMORPHISM; DYSLEXIA; DYSPRAXIA; EMBASE; ERYTHROCYTE LEVEL; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; HUMAN; HYPERACTIVITY; INFORMATION RETRIEVAL; LEARNING DISORDER; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; AGE FACTORS; ARACHIDONIC ACID; BLOOD CHEMICAL ANALYSIS; CHILD; DIET; ERYTHROCYTES; FATTY ACIDS; FEMALE; HUMANS; LEARNING DISORDERS; MALE; MEMBRANE LIPIDS; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 71749097866     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.09.001     Document Type: Article

References (115)

1. Stevens L.J., Zentall S.S., Abate M.L., Kuczek T., and Burgess J.R. Omega-3 fatty acids in boys with behavior, learning and health problems. Physiol. Behav. 59 (1996) 915-920
2. Taylor K.E., Higgins C.J., Calvin C.M., Hall J.A., Easton T., McDaid A.M., et al. Dyslexia in adults is associated with clinical signs of fatty acid deficiency. Prostaglandins Leukot. Essent. Fat Acids 63 (2000) 75-78
3. Richardson A.J., Calvin C.M., Clisby C., Schoenheimer D.R., Montgomery P., and Hall J.A. Fatty acid deficiency signs predict the severity of reading and related difficulties in dyslexic children. Prostaglandins Leukot. Essent. Fat Acids 63 (2000) 69-74
4. Mitchell E.A., Lewis S., and Cutler D.R. Essential fatty acids and maladjusted behavior in children. Prostaglandins Leukot. Med. 12 (1983) 281-287
5. Mitchell E.A., Aman M.G., Turbott S.H., Manku M.S., and Clinical M. characteristics and serum essential fatty acid levels in hyperactive children. Clin. Pediatr. 26 (1987) 406-411
6. Stevens J.L., Zentall S.S., Deck J.L., Abate M.L., Watkins B.A., Lipp S.R., and Burgess J.R. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am. J. Clin. Nutr. 62 (1995) 761-768
7. Burgess J.R., Stevens L., Zhang W., and Peck L. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am. J. Clin. Nutr. 71 Suppl. (2000) 327S-330S
8. Vancassel S., Durand G., Barthélémy C., et al. Plasma fatty acid levels in autistic children. Prostaglandins Leukot. Essent. Fat Acids 65 (2001) 1-7
9. Bell J.G., MacKinlay E.E., Dick J.D., MacDonald D.J., Boyle R.M., and Glen A.C.A. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot. Essent. Fat Acids 71 (2004) 201-204
10. Chen J.R., Hsu S.F., Hsu C.D., Hwang L.H., and Yang S.C. Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan. J. Nutr. Biochem. 15 (2004) 467-472
11. Young G.S., Maharaj N.J., and Conquer J.A. Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder. Lipids 39 (2004) 117-123
12. Young G.S., Conquer J.A., and Thomas R. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipids fatty acid levels in adults with attention deficit hyperactivity disorder. Reprod. Nutr. Dev. 45 (2005) 549-558
13. Antalis C.J., Stevens L.J., Campbell M., Pazdro R., Ericson K., and Burgess J.R. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot. Essent. Fat Acids 75 (2006) 299-308
14. Joshi K., Lad S., Kale M., et al. Supplementation with flax oil and vitamin C improves the outcome of attention deficit hyperactivity disorder (ADHD). Prostaglandins Leukot. Essent. Fat Acids 74 (2006) 17-21
15. Richardson A.J. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int. Rev. Psychiatry 18 (2006) 155-172
16. Bourre J.M. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J. Nutr. Health Aging 8 (2004) 163-174
17. McCann J.C., and Ames B.N. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am. J. Clin. Nutr. 82 (2005) 281-295
18. Muskiet F.A.J., Fokkema M.R., Schaafsma A., Boersma E.R., and Crawford M.A. Is docosahexaenoic acid (DHA) essential? Lessons from DHA status, regulation, our ancient diet, epidemiology and randomized controlled trials. J. Nutr. 134 (2004) 183-186
19. Rapoport S.I., Chang M.C., and Spector A.A. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid Res. 42 (2001) 678-685
20. Horrobin D.F., and Bennett C.N. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, aging and osteoporosis: possible candidate genes. Prostaglandins Leukot. Essent. Fat Acids 60 (1999) 217-234
21. Wainwright P.E. Dietary essential fatty acids and brain function: a developmental perspective on mechanisms. Proc. Nutr. Soc. 61 (2002) 61-69
22. Lukiw W., Cui J.G., Marcheselli V.L., et al. A role for DHA-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 115 (2005) 2774-2783
23. Calon F., Lim G.P., Yang F., et al. Docosahexaenoic acid protects from dendritic pathology in an Azheimer's disease mouse model. Neuron 43 (2004) 633-645
24. Calon F., Lim G.P., Morihara T., et al. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur. J. Neurosci. 22 (2005) 617-626
25. Hashimoto M., Tanabe Y., Fujii Y., Kikuta T., Shibata H., and Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J. Nutr. 135 (2005) 549-555
26. Gamoh S., Hashimoto M., Hossain S., and Masumura S. Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats. Clin. Exp. Pharmacol. 28 (2001) 266-270
27. Piomelli D. Arachidonic acid. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology-The Fourth Generation of Progress (1995), Raven Press, New York 595-607
28. Hansen H.S., and Artmann A. Endocannabinoids and nutrition. J. Neuroendocrinol. 20 (2008) 94-99
29. Plourde M., and Cunnane S.C. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl. Physiol. Nutr. Metab. 32 (2007) 619-634
30. Innis S.M. Perinatal biochemistry and physiology of long chain polyunsaturated fatty acids. J. Pediatr. 143 (2003) 81-88
31. Colter A.L., Culter C., and Meckling K.A. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. Nutr. J. 7 (2008) 1-11 10.1187/1475-2891-7-8
32. Metcalf R., James M., and Mantzioris C. A practical approach to increasing intakes of n-3 polyunsaturated fatty acids: use of novel foods enriched with n-3 fats. Eur. J. Clin. Nutr. 57 (2003) 1605-1612
33. Meyer B.J., Mann N.J., Lewis J.L., Milligan G.C., Sinclair A.J., and Howe P.R. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 38 (2003) 391-398
34. Otto S., van Houwelingen A., Badart-Smook A., and Hornstra G. Changes in maternal essential fatty acid profile during early pregnancy and the relation of the profile to diet. Am. J. Clin. Nutr. 73 (2001) 302-307
35. DeVriese S.R., Henauw S., Backer G., Dhont M., and Christophe A.B. Estimation of dietary fat intake of Belgian pregnant women. Ann. Nutr. Metab. 45 (2001) 273-278
36. J. Buttriss, Omega-3 Fatty Acids and Health, British Nutrition Foundation Briefing Paper, Nutr. Bull. 24 (1999) 61-126
37. Denomme J., Stark K., and Holub B. Directly quantitated dietary n-3 fatty acid intakes of pregnant Canadian women are lower than current dietary recommendations. J. Nutr. 135 (2005) 206-211
38. Innis S.M., and Elias S.L. Intakes of essential n-6 and n-3 polyunsaturated fatty acids among pregnant Canadian women. Am. J. Clin. Nutr. 77 (2003) 473-478
39. Sioen I., Pynaert I., Matthys C., De Backer G., Van Camp J., and De Henauw S. Dietary intakes and food sources of fatty acids for Belgian women, focused on n-6 and n-3 polyunsaturated fatty acids. Lipids 41 (2006) 415-422
40. Astorg P., Arnault N., Czernichow S., Noisette N., Galan P., and Hereberg S. Dietary intakes and food sources of n-6 and n-3 PUFA in French adult men and women. Lipids 39 (2004) 527-535
41. Kris-Etherton P., Taylor D., Yu-Poth S., et al. Polyunsaturated fatty acids in the food chain in the United States. Am. J. Clin. Nutr. 71 Suppl. (2000) 179S-1790
42. Stark K.D., Beblo S., Murthy M., et al. Comparison of bloodstream fatty acid composition from African-American women at gestation, delivery, and postpartum. J. Lipid Res. 46 (2005) 516-525
43. Fratesi J.A., Hogg R.C., Young-Newton G.S., et al. Direct quantitation of omega-3 fatty acid intake of Canadian residents of a long-term care facility. Appl. Physiol. Nutr. 34 (2009) 1-9
44. Astorg P., Bertrais S., Laporte F., et al. Plasma n-6 and n-3 polyunsaturated fatty acids as biomarkers of their dietary intakes: a cross-sectional study within a cohort of middle-aged French men and women. Eur. J. Clin. Nutr. 62 (2008) 1155-1161
45. Kornsteiner M., Singer I., and Elmadfa I. Very low n-3 long chain polyunsaturated fatty acid status in Austrian vegetarians and vegans. Ann. Nutr. Metab. 52 (2008) 37-47
46. Parra-Cabrera S., Moreno-Macias H., Mendez-Ramirez I., Schnaas L., and Romieu I. Maternal dietary omega fatty acid intake and auditory brainstem-evoked potentials in Mexican infants born at term: cluster analysis. Early Hum. Dev. 84 (2008) 51-57
47. Lakin V., Haggarty P., Abramovich D.R., et al. Dietary intake and tissue concentration of fatty acids in omnivore, vegetarian and diabetic pregnancy. Prostaglandins Leukot. Essent. Fat Acids 59 (1998) 209-220
48. Xie L., and Innis S.M. Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J. Nutr. 138 (2008) 2222-2228
49. Flood V.M., Webb K.L., Rochtchina E., Kelly B., and Mitchell P. Fatty acid intakes and food sources in a population of older Australians. Asia Pac. J. Clin. Nutr. 16 (2007) 322-330
50. Norris J.M., Xiang Y., Molly M.L., et al. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for Type 1 diabetes. JAMA 298 (2007) 1420-1428
51. Sioen I., Huybrechts I., Verbeke W., Van Camp J., and De Henauw S. n-6 and n-3 PUFA intakes of pre-school children in Flanders, Belgium. Br. J. Nutr. 98 (2007) 819-825
52. Madden S.M., Garrioch C.F., and Holub B.J. Direct diet quantification indicates low intakes of (n-3) fatty acids in children 4 to 8 years old. J. Nutr. 139 (2009) 528-532
53. Colter A.L., Cutler C., and Meckling K.A. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. Nutr. J. 7 (2008) 8 10.1186/1475-2891-7-8
54. L.M. Minns, E.H. Kerling, M.R. Curtis, J.R. Goetz, D.K. Sullivan, S.E. Carlson, Docosahexaenoic acid intake and status of US toddlers, in: Proceedings of the Eighth Meeting of the International Society for the Study of Fatty Acids and Lipids. 17-22 May 2008, Kansas City, MO, p. 95.
55. Orton H.D., Szabo N.J., Clare-Salzler M., and Norris J.M. Comparison between omega-3 and omega-6 polyunsaturated fatty acid intakes as assessed by a food frequency questionnaire and erthrocyte membrane fatty acid composition in young children. Eur. J. Clin. Nutr. 62 (2008) 733-738
56. Sioen I., Matthys C., De Backer G., Van Camp J., and De Henauw S. Importance of seafood as nutrient source in the diet of Belgian adolescents. J. Hum. Nutr. Diet 20 (2007) 580-589
57. International Society for the Study of Fatty Acids and Lipids. PUFA Recommendations. Internet: http://www.issfal.org.uk/pufa-recommendations.html (accessed 19 April 2008).
58. Scientific Consensus Workshop. Omega-3 fatty acids-essential nutrients for our children. Omega-3 Centre. September 2007, www.omega-3centre.com (accessed 13 February 2008).
59. Klein C.J. Nutrient requirements for preterm infant formulas. J. Nutr. 132 Suppl. 1 (2002) 1395S-13950
60. Kuipers R., Fokkema M., Smit E., van der Meulen J., Boersma E., and Muskiet F. High contents of both docosahexaenoic acid and arachidonic acids in milk of women consuming fish from Lake Katangiri (Tanzania) targets for infant formulae close to our ancient diet. Prostaglandins Leukot. Essent. Fat Acids 72 (2005) 279-288
61. Hamazaki T., and Okuyama H. The Japan Society for Lipids Nutrition recommendations to reduce the intake of linoleic acid: a review and critique of the scientific evidence. World Rev. Nutr. Diet 92 (2003) 109-132
62. Sorgi P.J., Hallowell E.M., Hutchins H.L., and Sears B. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Nutr. J. 6 (2007) 16
63. Spahis S., Vanasse M., Bélanger S.A., Ghadirian P., Grenier E., and Levy E. Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Prostaglandins Leukot. Essent. Fat Acids 79 (2008) 47-53
64. Bélanger S.A., Vanasse M., Spahis S., et al. Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: a randomized, double-blind, placebo-controlled study. Paediatr. Child Health 14 (2009) 89-98
65. Wiest M.M., German J.B., Harvey D.J., Watkins S.M., and Hertz-Picciotto I. Plasma fatty acid profiles in autism: a case-control study. Prostaglandins Leukot. Essent. Fat Acids 80 (2009) 221-227
66. Laasonen M., Hokkanen L., Leppämäki S., Tani P., and Erkkilä A.T. Project DyAdd: fatty acids in adult dyslexia, ADHD, and their comorbid combination. Prostaglandins Leukot. Essent. Fat Acids 81 (2009) 89-96
67. Gow R.V., Matsudaira T., and Taylor E. Total red blood cell concentrations of ω-3 fatty acids are associated with emotion-elicited neural activity in adolescent boys with attention-deficit hyperactivity disorder. Prostaglandins Leukot. Essent. Fat Acids 80 (2009) 151-156
68. Cyhlarova E., Bell J.G., Dick J.R., MacKinlay E.E., Stein J.F., and Richardson A.J. Membrane fatty acids, reading and spelling in dyslexic and non-dyslexic adults. Eur. Neuropsychopharmacol. 17 (2007) 116-121
69. Giedd N.J., Blumenthal J., Jeffries N.O., et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat. Neurosci. 2 (1999) 861-863
70. Thompson P.M., Giedd J.N., Woods R.P., et al. Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature 404 (2000) 190-193
71. Sowell E.R., Thompson P.M., Holmes C.J., et al. In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat. Neurosci. 2 (1999) 859-861
72. Zeleniuch-Jacquotte A., Chajès V., Van Kappel A.L., Riboli E., and Toniolo P. Reliability of fatty acid composition in human serum phospholipids. Eur. J. Clin. Nutr. 54 (2000) 367-372
73. Stevens L., Zhang W., Peck L., et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids 38 (2003) 1007-1021
74. MacDonnell L.E., Skinner F.K., Ward P.E., et al. Increased levels of cytosolic phospholipase A2 in dyslexics. Prostaglandins Leukot. Essent. Fat Acids 63 (2000) 37-39
75. Brookes K.J., Chen W., Xy X., et al. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol. Psychiatry 60 (2006) 1053-1061
76. Malerba G., Schaeffer L., Xumerle L., et al. SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 44 (2008) 288-299
77. Schaeffer L., Muller H., Heid I.M., et al. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum. Mol. Genet. 15 (2006) 1745-1756
78. Rzehak P., Heinrich J., Klopp N., et al. Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes. Br. J. Nutr. 101 (2009) 20-26
79. B. Koletzko, H. Demmelmair, L. Schaeffer, T. Illig, J. Heinrich, Genetically determined variation in polyunsaturated fatty acid metabolism may result in different dietary requirements, Nestle Nutr. Workshop Ser. Pediatr. Program 62 (2008) 35-44.
80. Martinelli N., Girelli D., Malerba G., et al. FADS genetypes and desaturase activity estimated by the ration of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am. J. Clin. Nutr. 88 (2008) 941-949
81. Hibbeln J.H., Nieminen L.R.G., Blasbalg T.L., Riggs J.A., and Lands W.E.M. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am. J. Clin. Nutr. 83 Suppl (2006) 1483S-14830
82. Brenna J.T., Varamini B., Jensen R.G., Diersen-Shade D.A., Boettcher J.A., and Arterburn L.M. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am. J. Clin. Nutr. 85 (2007) 1457-1464
83. Pawlosky R.J., Hibbeln J.R., Novotny J.A., and Salem N. Physiological compartmental analysis of α-linolenic acid metabolism in adult humans. J. Lipid Res. 42 (2001) 1257-1265
84. Brady L.M., Lesauvage S.V.M., Saini N., Williams C.M., and Lovegrove J.A. Comparison of dietary fat and fatty acid intake estimated by duplicate diet collection techniques and estimated dietary records. J. Hum. Nutr. Diet. 16 (2003) 393-401
85. Mina K., Fritschi L., and Knuiman M. A valid semiquantitative food frequency questionnaire to measure fish consumption. Eur. J. Clin. Nutr. 61 (2007) 1023-1031
86. Leaf A., and Weber P.C. A new era for science in nutrition. Am. J. Clin. Nutr. 45 (1987) 1018-1053
87. Boyd Eaton S., Eaton S.B., Sinclair A.J., Cordain L., and Mann N.J. Dietary intake of long-chain polyunsaturated fatty acids during the Paleolithic. In: Simopoulos A.P. (Ed). The Return of ω3 Fatty Acids into the Food Supply. I. Land-Based Animal Food Products and Their Health Effects, World Rev. Nutr. Diet (1998), Karger, Basel 12-23
88. Rapoport S.I., Rao J.S., and Igarashi M. Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot. Essent. Fat Acids 77 (2007) 251-261
89. Calder P.C. Dietary arachidonic acid: harmful, harmless or helpful. Br. J. Nutr. 98 (2007) 451-453
90. Crawford M.A., Costeloe K., Ghebremeskel K., Phylactos A., Skirvin L., and Stacey F. Are deficits of arachidonic acid and docosahexaenoic acids responsible for the neural and vascular complications of preterm babies. Am. J. Clin. Nutr. 66 Suppl. (1997) 1032S-10320
91. Bitsanis D., Crawford M.A., Moodley T., Holmsen H., Ghebremeskel K., and Djahanbakhch O. Arachidonic acid predominates in the membrane phosphoglycerides of the early and term human placenta. J. Nutr. 135 (2005) 2566-2571
92. 13C-unsaturated fatty acids in healthy women. J. Lipid Res. 45 (2004) 474-485
93. Von Schacky C., Fischer S., and Weber P. Long-term effects of dietary marine ω-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J. Clin. Invest. 76 (1985) 1626-1631
94. Harris W.S., Sands S.A., Windsor S.L., et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 110 (2004) 1645-1649
95. Elizondo A., Araya J., Rodrigo R., et al. Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients. Obesity 15 (2007) 24-31
96. Pan D.A., Lillioja S., Milner M., et al. Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J. Clin. Invest. 96 (1995) 2802-2808
97. Damsgaard C.T., Frokiaer H., and Lauritzen L. The effects of fish oil and high or low linoleic acid intake on fatty acid composition of human peripheral blood mononuclear cells. Br. J. Nutr. 99 (2008) 147-154
98. Kew S., Mesa M., Tricon S., Buckley R., Minihane A., and Yaqoob P. Effects of oils rich in eicosapentaenooic acid and docosahexaenoic acids on immune cell composition and function in healthy humans. Am. J. Clin. Nutr. 79 (2004) 674-681
99. van Staveren W.A., Deuenberg P., Katan M.B., Burema J., de Groot L.C., and Hoffmans M.D. Validity of the fatty acid composition of subcutaneous fat tissue microbiopsies as an estimate of the long-term average fatty acid composition of the diet of separate individuals. Am. J. Epidemiol. 123 (1986) 455-463
100. Lands W.E.M. Long-term fat intake and biomarkers. Am. J. Clin. Nutr. 61 Suppl (1995) 721S-7210
101. R. Raz, L. Gabis, Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review, Dev. Med. Child Neurol. 2009 22 June [Epub ahead of print] 10.1111/j1469-8749.2009.03351.x.
102. Aman M.G., Mitchell E.A., Turbott S.H., et al. The effects of essential fatty acid supplementation by Efamol in hyperactive children. J. Abnorm. Child Psychol. 15 (1987) 75-90
103. Arnold L.E., KleyKamp D., Votolato M.A., et al. Gamma-linolenic acid for attention-deficit hyperactivity disorder: placebo-controlled comparison to D-amphetamion. Biol. Psychiatry 25 (1989) 222-228
104. Richardson A.J., and Puri B.K. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuro-psychopharmacol. Biol. Psychiatry 26 (2002) 233-239
105. Richardson A., and Montgomery P. The Oxford-Durham study: a randomized controlled trial of fatty acid supplementation in children with developmental coordination disorder. Pediatrics 115 (2005) 1360-1366
106. Sinn N., and Bryan J. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD. J. Dev. Behav. Pediatr. 28 (2007) 82-91
107. Johnson M., Ostlund S., Fransson G., et al. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J. Atten. Disord. 12 (2009) 394-401
108. T. Matsudaira, A. Ibrahimovic, R. Gow, et al. Omega-3 fatty acid supplementation of adolescent boys with symptoms of attention deficit hyperactivity disorder: a double-blind, randomized controlled trial, in: Proceedings of the Eighth Meeting of ISSFAL, Kansas City, USA, Poster presentation P120, 19 May 2008, p. 152.
109. Hamazaki T., and Hirayaman S. The effect of docoshexaenoic acid containing food administration on symptoms of attention deficit/hyperactivity disorder-a placebo controlled, double-blind study. J. Clin. Nutr. 58 (2004) 838
110. P.A. Gustafsson, U. Birberg-thornberg, K. Duchén, T. Karlsson, Randomized placebo controlled trial of PLUSEPA (Omega-3) as treatment for attention deficit hyperactivity disorder (ADHD) in children ages 7-12, in: Proceedings of the Eighth Meeting of ISSFAL, Kansas City, USA, Oral Presentation in Concurrent Session 25-Neuropsychology II, 22 May 2008, p. 219.
111. Voigt G., Llorente A.M., Jensen C.L., Fraley J.K., Berretta M.C., and Heird W.C. Randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J. Pediatr. 139 (2001) 189-196
112. Cunnane S.C., Ryan M.A., Nadeau C.R., et al. Why is carbon from some polyunsaturates extensively recycled into lipid synthesis. Lipids 38 (2003) 477-484
113. Yamada J., and Banks A. Evidence for and characteristics of dyslexia among Japanese children. In: Schatschneider C., and Compton D. (Eds). Annals of Dyslexia (1994), Springer, New York, USA 103-119
114. Kuriki K., Nagaya T., Tokudome Y., et al. Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study. J. Nutr. 133 (2003) 3643-3650
115. Hadley K.B., Ryan A.S., Nelson E.B., and Salem N. An assessment of dietary docosahexaenoic acid requirements for brain accretion and turnover during early childhood. In: Simopoulos A.P., and Bazan N.G. (Eds). World Review of Nutrition and Dietetics (2009), Karger, Basel, Switzerland 97-104